Inhalation CDMO Market Outlook from 2024 to 2034

The global inhalation CDMO industry is expected to expand at a CAGR of 5.7% in the forecast period 2024 to 2034. The market value is projected to increase from US$ 8,639.1 million in 2024 to US$ 14,863.6 million in 2034.

Attributes Key Insights
Base Value, 2023 US$ 8,144.2 million
Estimated Global Inhalation CDMO Market Size (2024E) US$ 8,639.1 million
Forecast Inhalation CDMO Market Value (2034F) US$ 14,863.6 million
Value-based CAGR (2024 to 2034) 5.7%

The pharmaceutical landscape is undergoing a transformative phase marked by continual innovations in inhalation drug delivery systems, constituting a pivotal driver for the contract development and manufacturing organization (CDMO) market. This evolution encompasses a spectrum of advanced technologies, emphasizing dry powder inhalers (DPIs), metered-dose inhalers (MDIs), and nebulizers.

As respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) become increasingly prevalent, the demand for efficacious and patient-friendly inhalation therapies escalates. Consequently, pharmaceutical companies are propelled to seek the expertise of specialized CDMOs to navigate the intricacies of these evolving delivery systems.

Formulation development, analytical testing, process optimization, and the production of inhalable medicinal products are the services provided by inhalation CDMOs. They could also help patients navigate the legal and regulatory procedures for developing respiratory drugs.

The expansion of the inhalation CDMO market is facilitated by advancements in inhalation technology, including the creation of unique medication formulations and inventive inhaler devices. Companies in this industry constantly invest in research & development to be on the cutting edge of technological advancements.

The inhalation CDMO market is expanding internationally, with firms offering their services to customers in several geographical areas. Pharmaceutical firms and inhalation CDMOs are increasingly forming partnerships and collaborations to pool resources and expertise.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2019 to 2023 Inhalation CDMO Market Sales Outlook Vs. 2024 to 2034 Forecast

The global inhalation CDMO market recorded a historical CAGR of 4.0% from 2019 to 2023. The increasing prevalence of asthma and COPD drives the incidence of associated respiratory diseases.

In recent years, this has led to a surging demand for efficient respiratory care, including using respiratory inhaler devices. Healthcare professionals are increasingly inclined to adopt inhaler devices to deliver drugs directly to patients' respiratory tracts to ensure minimal wastage of drugs and to increase their efficacy.

The inhalation CDMO market experienced a notable impact from the escalating prevalence of asthma and chronic obstructive pulmonary disease (COPD). The rising incidence of these respiratory conditions has propelled the demand for inhaler devices, becoming a central driver in shaping the market dynamics.

The increasing prevalence of asthma and COPD has led to a growing patient population requiring long-term management and treatment. As a result, there is a heightened need for effective and convenient drug delivery systems, with inhaler devices emerging as a cornerstone in the therapeutic arsenal for these respiratory disorders.

The adoption of newly launched nebulizers with quick drug delivery inhalers would aid demand. In addition, a top-end technological assessment with greater accuracy is gaining traction among the population, further spurring revenue growth for the market.

The relentless pace of technological advancement is a driving force fueling the demand for respiratory inhaler devices and shaping the landscape of the respiratory healthcare market. Technical assessment plays a pivotal role in enhancing the capabilities and functionalities of inhaler devices.

The symbiotic relationship between technology and respiratory care drives the market toward innovative solutions. These would help offer improved patient outcomes, increased treatment adherence, and enhanced disease management.

Insights into Lucrative Opportunities Propelling Inhalation CDMO Demand

  • The trend toward personalized medicine and targeted therapies is poised to reshape the landscape of inhalation drug development, concurrently driving demand for (CDMO) services.
  • As pharmaceutical research pivots toward tailoring treatments to individual patient profiles, the demand for inhalation drugs customized to specific populations escalates.
  • The rising life expectancy rate is expected to boost the growth of the respiratory inhaler device market due to the high prevalence of COPD among the older population.
  • As healthcare systems become more digitalized, inhaler devices facilitate more efficient communication between patients and healthcare providers. This connectivity fosters a collaborative approach to managing respiratory health, empowering patients to take an active role in their treatment.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Restrictive Factors for the Inhalation CDMO Market

  • The progression of inhalation drug delivery systems, marked by the integration of advanced technologies, introduces a substantial financial burden for contract development and manufacturing organizations.
  • The inhalation CDMO market confronts a significant hurdle in the form of stringent regulatory requirements and dynamic compliance standards.
  • It can be difficult and expensive to keep up with the latest developments and implement them into industrial processes.
  • Spending on pharmaceuticals and healthcare can be impacted by economic downturns or uncertainties, which could result in a decline in the market for inhalation goods.

Comparative View of Adjacent Inhalation CDMO Markets

The peer or tangential markets in the healthcare division will likely impact the inhalation CDMO market. These include other types of markets, such as the cosmetic CDMO industry and CMO/CDMO industry.

Demand for inhalation CDMO is projected to expand at a 6.4% CAGR during the forecast period. Growing demand for customized solutions and flexible manufacturing options are driving inhalation of CDMO market growth.

On the contrary, the CMO/CDMO industry is poised to thrive at a higher CAGR of 5.7% through 2034. There is an increasing need for contract services in the manufacturing of biologics and biopharmaceuticals. CMOs and CDMOs are focusing on supporting the manufacturing of complicated biological products, such as gene therapies, cell-based medicines, and monoclonal antibodies.

The cosmetic CDMO industry is projected to expand at a CAGR of 5.8% from 2024 to 2034. Cosmetic CDMOs are investing in research & development to produce innovative formulas that target specific skincare issues and use cutting-edge, high-performing components.

Inhalation CDMO Market:

Attributes Inhalation CDMO Market
CAGR (2024 to 2034) 5.7%
Growth of Inhalation CDMO Market To meet the rising demand for their services, CDMOs are expanding their global presence. By establishing a foothold in significant pharmaceutical markets, these firms can enhance client service and tap into a wider array of prospects.
Inhalation CDMO Market Trend The increasing number of people suffering from respiratory conditions, including COPD and asthma, is fuelling the need for efficient inhalation treatments.

CMO/CDMO Market:

Attributes CMO/CDMO Market
CAGR (2024 to 2034) 5.7%
Growth Factor Sustainability of the environment is increasingly important in the CMO/CDMO sector. In order to meet sustainability objectives, companies are embracing green technologies, cutting waste, and putting eco-friendly strategies into action.
Key Trends For the purpose of increasing productivity, cutting expenses, and guaranteeing quality in manufacturing processes, CMOs and CDMOs are investing in technologies like artificial intelligence, real-time monitoring, and the internet of things.

Cosmetic CDMO Market:

Attributes Cosmetic CDMO Market
CAGR (2024 to 2034) 5.8%
Growth Factor To fulfill the growing demand for clean beauty goods, cosmetic CDMOs are using eco-friendly procedures, sustainable ingredient sourcing, and eco-friendly packaging solutions.
Key Trends The market for personalized and customized cosmetics is expanding. In response to this trend, cosmetic CDMOs are providing formulation development services that take into account customer preferences and distinctive product attributes.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

The table below shows the estimated growth rates of the top five countries. China, Japan, and Spain are set to record higher CAGRs of 10.8%, 4.9%, and 3.8%, respectively, through 2034.

Countries Value CAGR (2024 to 2034)
United States 2.6%
China 10.8%
Japan 4.9%
Germany 2.3%
Spain 3.8%

Growing Prevalence of Respiratory Disorders Boosting the United States Market

The United States dominated the global market and held a 33.1% market share in 2023. The United States is expected to exhibit a CAGR of 2.6% throughout the forecast period, driven by factors like:

The high prevalence of respiratory disorders such as asthma and COPD in the United States is a significant driver for the inhalation CDMO market. The demand for innovative inhalation therapies is surging, ultimately driving the growth of CDMOs in the United States.

Rising Demand for Pharmaceuticals to Aid Demand in China

In 2023, China held a dominant share of 7.7% in East Asia’s market. The market is expected to surge with a CAGR of 10.8% from 2024 to 2034. Some of the key drivers/trends include:

China faces a rising prevalence of respiratory disorders, including air pollution-related issues and an increasing number of smokers. This creates a substantial demand for advanced inhalation therapies, presenting an opportunity for CDMOs to cater to the growing healthcare needs in China.

China's pharmaceutical market is rapidly expanding, driven by a rising aging population, increased healthcare awareness, and high disposable income. This growth creates opportunities for CDMOs to collaborate with local and international pharmaceutical companies seeking inhalation drug development services.

Expansion of Pharmaceutical Industry Fueling Demand in Germany

Germany is expected to surge at a CAGR of 2.3% during the forecast period. This can be attributed to factors like:

Germany is a pharmaceutical hub with a strong emphasis on research and development activities. The country's well-established pharmaceutical industry demands specialized CDMOs, particularly those offering inhalation drug development expertise.

Germany's central location in Europe is a strategic base for companies that serve Europe’s pharmaceutical market. Inhalation CDMOs can leverage this location to establish a presence and cater to the diverse needs of the pharmaceutical industry.

Favorable Government Policies and Support to Boost Growth in Japan

Japan is set to surge at a CAGR of 4.9% between 2024 and 2034. Factors driving the market growth include:

In Japan, there is a high frequency of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), which drives up demand for inhalation treatments. As a result, inhalation CDMOs now have the chance to work with pharmaceutical firms to develop and produce respiratory medicinal products.

Japan has a solid pharmaceutical regulation system in place. Operating in Japan, inhalation CDMOs must navigate and abide by the rules established by the Pharmaceuticals and Medical Devices Agency (PMDA). Comprehending and obeying these rules is essential to developing and effectively launching new products in the market.

Japan is renowned for its technological breakthroughs. The country’s inventive research and development in inhalation medication delivery methods and technologies can benefit inhalation CDMOs operating nationwide. Being at the forefront of these developments enables companies to provide their clients with state-of-the-art solutions.

Changing Consumer Preference to Fuel Demand in Spain

Over the forecast period, demand for inhalation CDMO in Spain is expected to rise at a CAGR of 3.8%. This growth projection can be attributed to several key factors:

Spain is a vital country in the global pharmaceuticals market. Spain-based inhalation CDMOs can expand their offerings to serve clients abroad or collaborate with multinational pharmaceutical firms. Incorporating this integration with the global market can yield supplementary growth prospects.

The aging population of Spain is driving up demand for healthcare services and pushing the inhalation CDMO market. The elderly are more likely to suffer from respiratory disorders, which makes effective inhalation therapy necessary. By creating specialized respiratory therapies, inhalation CDMOs can help satisfy these healthcare demands.

For inhalation CDMOs, it is crucial to consider Spain’s market trends and cultural preferences. Inhalable medicine products can succeed more in Spain’s market if their formulations and delivery methods are customized to suit regional tastes and medical standards.

Category-wise Insights

The below section shows the commercial segment dominating by scale of operation. It is expected to surge at a CAGR of 6.3% by 2034. Based on product, the API segment is anticipated to rise at a 6.0% CAGR by 2034.

Segment Value CAGR (2024 to 2034)
Commercial (Scale of Operation) 6.3%
Formulation Development (Services) 4.5%
API (Product) 6.0%
Medium (Company Size) 3.6%

API to Dominate the Inhalation CDMO Market

  • API forms the core component of several pharmaceutical products, including inhalation therapies. It's the active substance responsible for the desired therapeutic effect.
  • Inhalation therapies use APIs in aerosolized or powdered forms for direct delivery to the respiratory system, with each therapy requiring a unique formulation based on API characteristics and delivery device.
  • CDMOs specializing in inhalation APIs offer customization and optimization services to meet the precise requirements of their clients, leading to enhanced therapeutic outcomes and patient compliance.
  • API segment is the leading segment in the inhalation CDMO market due to its pivotal role in the development and manufacturing of inhalation therapies.

Most of the Revenue to be Generated by Formulation Development Through 2034

  • Inhalation formulations are complex and require specialized expertise to ensure optimal delivery of the active pharmaceutical ingredient to the respiratory system.
  • CDMOs with expertise in formulation development offer tailored solutions to meet the specific requirements of their clients, driving demand for their services.
  • The segment is a significant revenue generator in the inhalation CDMO market due to its complexity, device compatibility, regulatory compliance, and demand for innovative products.

Commercial Operation to Remain the Most Sought-after Scale of Operation

  • Rising prevalence of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is driving demand for inhalation therapies.
  • Pharmaceutical companies are increasingly focusing on the commercialization of inhalation products to address this growing patient population.
  • Inhalation therapies offer several advantages over conventional oral or injectable routes of drug administration, including targeted delivery to the respiratory system, reduced systemic side effects, and improved patient compliance.
  • Shift toward inhalation therapies for the treatment of respiratory diseases is driving demand for contract manufacturing services to support commercial-scale production.

Competitive Landscape

Collaborations and acquisitions are common growth strategies that leading companies employ in the inhalation CDMO market. They aim to enhance their capabilities, expand their service offerings, and stay competitive in the dynamic landscape.

For instance

  • In March 2023, Stevanato and Recipharm collaborated to improve soft mist inhalers.
  • In December 2022, Recipharm announced extension of commercial manufacturing to support RedHill Biopharma's Talicia® to 2026.
  • In September 2022, Stevanato Group and Gerresheimer AG collaborated to develop an innovative ready-to-use vial platform for the pharmaceutical industry.

Scope of the Report

Attribute Details
Estimated Market Size (2024) US$ 8,639.1 million
Forecast Market Value (2034) US$ 14,863.6 million
Anticipated Growth Rate (2024 to 2034) 5.7%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis US$ million for Value
Key Regions Covered North America; Latin America; East Asia; South Asia and Pacific; Western Europe; Eastern Europe; Middle East and Africa
Key Countries Covered United States, Canada, Mexico, Brazil, Chile, China, Japan, South Korea, Germany, France, Spain, Italy, BENELUX, Nordic Countries, United Kingdom, BENELUX, Poland, Hungary, Romania, India, ASEAN Countries, Australia and New Zealand, GCC Countries, South Africa, and Türkiye
Key Market Segments Covered Service, Product, Company Size, Scale of Operation, and Region
Key Companies Profiled Recipharm AB; AptarGroup, Inc.; Hovione; Vectura Group Ltd; Nemera; Kindeva; H&T Presspart; Sanner GmbH; Stevanato Group; Medspray; ICONOVO AB; Lonza; Gerresheimer AG; Catalent; Patheon N.V. (Thermo Fisher Scientific, Inc.); Lubrizol Life Science; Enteris BioPharma; Cambrex Corporation; INKE; Piramal Pharma Limited; Lupin
Report Coverage Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities, Trends Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Inhalation CDMO Market Segmentation by Category

By Service:

  • Formulation Development
  • Device Development and Manufacturing
  • Clinical Manufacturing
  • Scale-up and Tech Transfer
  • Quality Control and Quality Assurance
  • Technology and Innovation
  • Regulatory Assistance
  • Analytical Services

By Product:

  • API
    • API Substrate
    • Large Molecule
    • Small Molecule
  • Inhalation Platform
    • Dry Powder Inhaler (DPIs)
    • Metered Dose Inhaler (MDIs)
    • Soft Mist Inhaler

By Company Size:

  • Large
  • Medium
  • Small

By Scale of Operation:

  • Preclinical
  • Clinical
  • Commercial

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • Middle East and Africa

Frequently Asked Questions

How big is the inhalation CDMO market?

The global market was valued at US$ 8,144.2 million in 2023.

What is the global market’s projected value for 2034?

The market is set to reach a valuation of US$ 14,863.6 million by 2034.

What was the last 4 years’ CAGR for the global market?

Demand for inhalation CDMO increased at a 5.7% CAGR from 2019 to 2023.

What will be the market size of CDMO by 2024?

The global market is projected to reach US$ 8,639.1 million by 2024.

What is the United States market outlook?

The United States accounted for a 33.1% share of the global market in 2023.

What is Germany’s market outlook?

Germany held around 2.3% market share in 2023.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

4. Value-Added Insights

    4.1. Service Adoption / Usage Analysis, By

    4.2. Disease Epidemiology, By Key Countries

    4.3. Regulatory Scenario

        4.3.1. Regulatory Frameworks in United States

        4.3.2. Regulatory Frameworks in Canada

        4.3.3. Regulatory Frameworks in Europe

        4.3.4. Regulatory Frameworks in China

        4.3.5. Regulatory Frameworks in Japan

        4.3.6. Regulatory Frameworks in India

    4.4. Overview of CRO and CDMO Services

    4.5. Role of Contract Service Providers

    4.6. Overview of CDMO with a Wide Array of Dosage Form Capabilities

    4.7. PESTLE Analysis

    4.8. Pharma Services Supply Chain Analysis

    4.9. Value Chain Analysis

    4.10. Sustainability Analysis and its Implications on Propellant Market Dynamics

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure

        5.1.2. R&D Funding Outlook, By Region

        5.1.3. R&D Funding Outlook, By Country

        5.1.4. Global API CDMO Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growing Prevalence of Respiratory Diseases

        5.2.2. Advancements in Inhalation Technology

        5.2.3. Increasing Focus on Personalized Medicine

        5.2.4. Rising Demand for Generic and Biosimilar Inhalation Products

        5.2.5. Regulatory Changes and Compliance Requirements

        5.2.6. Increasing Outsourcing of Inhalation Product Development

        5.2.7. Globalization of Pharmaceutical Supply Chains

        5.2.8. Emerging Markets and Untapped Opportunities

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    6.1. Historical Market Value (US$ million) Analysis, 2019 to 2023

    6.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ million) Analysis By Services, 2019 to 2023

    7.3. Current and Future Market Size (US$ million) Analysis and Forecast By Services, 2024 to 2034

        7.3.1. Formulation Development

        7.3.2. Device Development and Manufacturing

        7.3.3. Clinical Manufacturing

        7.3.4. Scale-up and Tech Transfer

        7.3.5. Quality Control and Quality Assurance

        7.3.6. Technology and Innovation

        7.3.7. Regulatory Assistance

        7.3.8. Analytical Services

    7.4. Market Attractiveness Analysis By Services

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ million) By Product, 2019 to 2023

    8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Product, 2024 to 2034

        8.3.1. API

            8.3.1.1. API Substrate

            8.3.1.2. Large Molecule

            8.3.1.3. Small Molecule

        8.3.2. Inhalation Platform

            8.3.2.1. Dry Powder Inhalers (DPIs)

            8.3.2.2. Metered Dose Inhalers (MDIs)

            8.3.2.3. Soft Mist Inhaler

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ million) By Company Size, 2019 to 2023

    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Company Size, 2024 to 2034

        9.3.1. Large

        9.3.2. Medium

        9.3.3. Small

    9.4. Market Attractiveness Analysis By Company Size

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Scale of Operation

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ million) By Scale of Operation, 2019 to 2023

    10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Scale of Operation, 2024 to 2034

        10.3.1. Preclinical

        10.3.2. Clinical

        10.3.3. Commercial

    10.4. Market Attractiveness Analysis By Scale of Operation

11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ million) Trend Analysis by Region, 2019 to 2023

    11.3. Current and Future Market Size (US$ million) Analysis and Forecast by Region, 2024 to 2034

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. East Asia

        11.3.4. South Asia & Pacific

        11.3.5. Western Europe

        11.3.6. Eastern Europe

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis by Region

12. North America Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    12.1. Introduction

    12.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        12.3.1. By Country

            12.3.1.1. United States

            12.3.1.2. Canada

        12.3.2. By Services

        12.3.3. By Product

        12.3.4. By Company Size

        12.3.5. By Scale of Operation

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Services

        12.4.3. By Product

        12.4.4. By Company Size

        12.4.5. By Scale of Operation

    12.5. Market Trends

    12.6. Drivers & Restraints Impact Analysis

    12.7. Country-Wise Analysis

        12.7.1. United States Market Analysis

            12.7.1.1. Introduction

            12.7.1.2. Market Analysis and Forecast by Market Taxonomy

                12.7.1.2.1. By Services

                12.7.1.2.2. By Product

                12.7.1.2.3. By Company Size

                12.7.1.2.4. By Scale of Operation

        12.7.2. Canada Market Analysis

            12.7.2.1. Introduction

            12.7.2.2. Market Analysis and Forecast by Market Taxonomy

                12.7.2.2.1. By Services

                12.7.2.2.2. By Product

                12.7.2.2.3. By Company Size

                12.7.2.2.4. By Scale of Operation

        12.7.3. Mexico Market Analysis

            12.7.3.1. Introduction

            12.7.3.2. Market Analysis and Forecast by Market Taxonomy

                12.7.3.2.1. By Services

                12.7.3.2.2. By Product

                12.7.3.2.3. By Company Size

                12.7.3.2.4. By Scale of Operation

13. Latin America Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    13.1. Introduction

    13.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Chile

            13.3.1.3. Rest of Latin America

        13.3.2. By Services

        13.3.3. By Product

        13.3.4. By Company Size

        13.3.5. By Scale of Operation

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Services

        13.4.3. By Product

        13.4.4. By Company Size

        13.4.5. By Scale of Operation

    13.5. Market Trends

    13.6. Drivers & Restraints Impact Analysis

    13.7. Country-Wise Analysis

        13.7.1. Brazil Market Analysis

            13.7.1.1. Introduction

            13.7.1.2. Market Analysis and Forecast by Market Taxonomy

                13.7.1.2.1. By Services

                13.7.1.2.2. By Product

                13.7.1.2.3. By Company Size

                13.7.1.2.4. By Scale of Operation

        13.7.2. Chile Market Analysis

            13.7.2.1. Introduction

            13.7.2.2. Market Analysis and Forecast by Market Taxonomy

                13.7.2.2.1. By Services

                13.7.2.2.2. By Product

                13.7.2.2.3. By Company Size

                13.7.2.2.4. By Scale of Operation

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    14.1. Introduction

    14.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    14.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Services

        14.3.3. By Product

        14.3.4. By Company Size

        14.3.5. By Scale of Operation

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Services

        14.4.3. By Product

        14.4.4. By Company Size

        14.4.5. By Scale of Operation

    14.5. Market Trends

    14.6. Drivers & Restraints Impact Analysis

    14.7. Country-Wise Analysis

        14.7.1. China Market Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Services

                14.7.1.2.2. By Product

                14.7.1.2.3. By Company Size

                14.7.1.2.4. By Scale of Operation

        14.7.2. Japan Market Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Services

                14.7.2.2.2. By Product

                14.7.2.2.3. By Company Size

                14.7.2.2.4. By Scale of Operation

        14.7.3. South Korea Market Analysis

            14.7.3.1. Introduction

            14.7.3.2. Market Analysis and Forecast by Market Taxonomy

                14.7.3.2.1. By Services

                14.7.3.2.2. By Product

                14.7.3.2.3. By Company Size

                14.7.3.2.4. By Scale of Operation

15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    15.1. Introduction

    15.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    15.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. ASEAN Countries

            15.3.1.3. Australia & New Zealand

            15.3.1.4. Rest of South Asia

        15.3.2. By Services

        15.3.3. By Product

        15.3.4. By Company Size

        15.3.5. By Scale of Operation

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Services

        15.4.3. By Product

        15.4.4. By Company Size

        15.4.5. By Scale of Operation

    15.5. Market Trends

    15.6. Drivers & Restraints Impact Analysis

    15.7. Country-Wise Analysis

        15.7.1. India Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Services

                15.7.1.2.2. By Product

                15.7.1.2.3. By Company Size

                15.7.1.2.4. By Scale of Operation

        15.7.2. ASEAN Countries Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Services

                15.7.2.2.2. By Product

                15.7.2.2.3. By Company Size

                15.7.2.2.4. By Scale of Operation

        15.7.3. Australia & New Zealand Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Services

                15.7.3.2.2. By Product

                15.7.3.2.3. By Company Size

                15.7.3.2.4. By Scale of Operation

16. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    16.1. Introduction

    16.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    16.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. France

            16.3.1.3. Spain

            16.3.1.4. Italy

            16.3.1.5. BENELUX

            16.3.1.6. Nordic Countries

            16.3.1.7. United Kingdom

            16.3.1.8. Rest of Western Europe

        16.3.2. By Services

        16.3.3. By Product

        16.3.4. By Company Size

        16.3.5. By Scale of Operation

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Services

        16.4.3. By Product

        16.4.4. By Company Size

        16.4.5. By Scale of Operation

    16.5. Market Trends

    16.6. Drivers & Restraints Impact Analysis

    16.7. Country-Wise Analysis

        16.7.1. Germany Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Services

                16.7.1.2.2. By Product

                16.7.1.2.3. By Company Size

                16.7.1.2.4. By Scale of Operation

        16.7.2. France Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Services

                16.7.2.2.2. By Product

                16.7.2.2.3. By Company Size

                16.7.2.2.4. By Scale of Operation

        16.7.3. Spain Market Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Services

                16.7.3.2.2. By Product

                16.7.3.2.3. By Company Size

                16.7.3.2.4. By Scale of Operation

        16.7.4. Italy Republic Market Analysis

            16.7.4.1. Introduction

            16.7.4.2. Market Analysis and Forecast by Market Taxonomy

                16.7.4.2.1. By Services

                16.7.4.2.2. By Product

                16.7.4.2.3. By Company Size

                16.7.4.2.4. By Scale of Operation

        16.7.5. BENELUX Republic Market Analysis

            16.7.5.1. Introduction

            16.7.5.2. Market Analysis and Forecast by Market Taxonomy

                16.7.5.2.1. By Services

                16.7.5.2.2. By Product

                16.7.5.2.3. By Company Size

                16.7.5.2.4. By Scale of Operation

        16.7.6. Nordic Countries Market Analysis

            16.7.6.1. Introduction

            16.7.6.2. Market Analysis and Forecast by Market Taxonomy

                16.7.6.2.1. By Services

                16.7.6.2.2. By Product

                16.7.6.2.3. By Company Size

                16.7.6.2.4. By Scale of Operation

        16.7.7. United Kingdom Market Analysis

            16.7.7.1. Introduction

            16.7.7.2. Market Analysis and Forecast by Market Taxonomy

                16.7.7.2.1. By Services

                16.7.7.2.2. By Product

                16.7.7.2.3. By Company Size

                16.7.7.2.4. By Scale of Operation

17. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    17.1. Introduction

    17.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    17.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        17.3.1. By Country

            17.3.1.1. Poland

            17.3.1.2. Hungary

            17.3.1.3. Russia

            17.3.1.4. Rest of Eastern Europe

        17.3.2. By Services

        17.3.3. By Product

        17.3.4. By Company Size

        17.3.5. By Scale of Operation

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Services

        17.4.3. By Product

        17.4.4. By Company Size

        17.4.5. By Scale of Operation

    17.5. Market Trends

    17.6. Drivers & Restraints Impact Analysis

    17.7. Country-Wise Analysis

        17.7.1. Poland Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Services

                17.7.1.2.2. By Product

                17.7.1.2.3. By Company Size

                17.7.1.2.4. By Scale of Operation

        17.7.2. Hungary Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Services

                17.7.2.2.2. By Product

                17.7.2.2.3. By Company Size

                17.7.2.2.4. By Scale of Operation

        17.7.3. Russia Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Services

                17.7.3.2.2. By Product

                17.7.3.2.3. By Company Size

                17.7.3.2.4. By Scale of Operation

18. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    18.1. Introduction

    18.2. Historical Market Size (US$ million) Trend Analysis by Market Taxonomy, 2019 to 2023

    18.3. Current and Future Market Size (US$ million) Analysis and Forecast by Market Taxonomy, 2024 to 2034

        18.3.1. By Country

            18.3.1.1. Saudi Arabia

            18.3.1.2. Türkiye

            18.3.1.3. South Africa

            18.3.1.4. Other African Union

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Services

        18.3.3. By Product

        18.3.4. By Company Size

        18.3.5. By Scale of Operation

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Services

        18.4.3. By Product

        18.4.4. By Company Size

        18.4.5. By Scale of Operation

    18.5. Market Trends

    18.6. Drivers & Restraints Impact Analysis

    18.7. Country-Wise Analysis

        18.7.1. Saudi Arabia Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Services

                18.7.1.2.2. By Product

                18.7.1.2.3. By Company Size

                18.7.1.2.4. By Scale of Operation

        18.7.2. Türkiye Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Services

                18.7.2.2.2. By Product

                18.7.2.2.3. By Company Size

                18.7.2.2.4. By Scale of Operation

        18.7.3. South Africa Market Analysis

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Services

                18.7.3.2.2. By Product

                18.7.3.2.3. By Company Size

                18.7.3.2.4. By Scale of Operation

        18.7.4. Other African Union Market Analysis

            18.7.4.1. Introduction

            18.7.4.2. Market Analysis and Forecast by Market Taxonomy

                18.7.4.2.1. By Services

                18.7.4.2.2. By Product

                18.7.4.2.3. By Inhalation Platform

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Top Devices CDMO’s Market Positioning

        19.2.1. Current Market Scenario (2024)

        19.2.2. Short Term Forecast (2025)

        19.2.3. Long Tem Forecast (2034)

    19.3. Market Share Assessment

    19.4. CDMO Market Insights

    19.5. Competition Deep Dive

        19.5.1. Recipharm AB

            19.5.1.1. Overview

            19.5.1.2. Inhalation Platform Portfolio

            19.5.1.3. Key Financials

            19.5.1.4. SWOT Analysis

            19.5.1.5. Key Developments

            19.5.1.6. Sales Footprint

            19.5.1.7. Strategy Overview

                19.5.1.7.1. Marketing Strategy

                19.5.1.7.2. Inhalation Platform Strategy

                19.5.1.7.3. Channel Strategy

        19.5.2. AptarGroup, Inc.

        19.5.3. Hovione

        19.5.4. Vectura Group Ltd.

        19.5.5. Nemera

        19.5.6. Kindeva

        19.5.7. H&T Presspart

        19.5.8. Sanner GmbH

        19.5.9. Stevanato Group

        19.5.10. Medspray

        19.5.11. ICONOVO AB

        19.5.12. Lonza

        19.5.13. Gerresheimer AG

        19.5.14. Catalent

        19.5.15. Patheon N.V. (Thermo Fisher Scientific, Inc.)

        19.5.16. Lubrizol Life Science

        19.5.17. Enteris BioPharma

        19.5.18. Cambrex Corporation

        19.5.19. INKE

        19.5.20. Piramal Pharma Limited

        19.5.21. Lupin

20. Assumptions and Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Small Molecule CMO/CDMO Market

November 2023

REP-GB-18438

January 2024

281 pages

Healthcare

Cosmetic CDMO Market

November 2023

REP-GB-18278

313 pages

Healthcare

CMO/CDMO Market

March 2021

REP-GB-13038

May 2023

292 pages

Healthcare

Small Molecule Innovator CDMO Market

March 2023

REP-GB-16887

333 pages

Explore Healthcare Insights

View Reports